SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-24-000453
Filing Date
2024-04-04
Accepted
2024-04-04 16:03:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC - DEFA14A lvrtx2024_defa14a.htm DEFA14A 9400
2 GRAPHIC check01.jpg GRAPHIC 1441
3 GRAPHIC logo.jpg GRAPHIC 9014
4 GRAPHIC lvrt_notice1.jpg GRAPHIC 244656
5 GRAPHIC lvrt_notice2.jpg GRAPHIC 229573
6 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-24-000453.txt   674580
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 24823113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)